SEC Form 4 · accession 0001104659-26-075709
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pravin Dugel
Officer — See Remarks · Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 18, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2026 | G | 50,092 | $0.00 | D | 2,547,078 | D | |
| Common Stock | Jun 16, 2026 | G | 50,092 | $0.00 | A | 50,092 | I | By spouse |
| Common Stock | holding | — | — | — | 694,811 | I | By Pravin Dugel 2024 Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration.
Remarks
Executive Chairman, President and CEO